Results 141 to 150 of about 11,492 (188)
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 3, Page 338-346, March 2026.Summary Background and Objective Despite the availability of guidelines and effective escalation therapies, chronic spontaneous urticaria (CSU) is often inadequately treated in Germany. Implementation science can help to transfer evidence‐based care into practice.
Ralph von Kiedrowski +10 more
wiley +1 more source
A Case of Palmoplantar Vesiculobullous Lesions
JEADV Clinical Practice, Volume 5, Issue 1, Page 315-318, March 2026.
Ali Abid +3 more
wiley +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 3, Page 338-348, March 2026.Zusammenfassung Hintergrund und Zielsetzung Trotz verfügbarer Leitlinien und effektiver Eskalationstherapien wird die chronisch spontane Urtikaria (CSU) in Deutschland häufig unzureichend behandelt. Implementation Science kann helfen, evidenzbasierte Versorgung in die Praxis zu überführen.
Ralph von Kiedrowski +10 more
wiley +1 more source
Therapeutic advances in pruritus as a model of personalized medicine
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 3, Page 415-422, March 2026.Recent advances in itch biology reveal that chronic pruritus arises from distinct neuroimmune pathways driven by cytokines, JAK, BTK and GPCRs. Targeted biologics and small molecule inhibitors such as dupilumab, nemolizumab, remibrutinib and JAK inhibitors precisely modulate these pathways, leading to a new era of personalized therapeutics in pruritus.
Kelsey Auyeung +2 more
wiley +1 more source
Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review. [PDF]
, 2014 D'Amato G +8 more
core +1 more source
Exploring the Disease Duration of Urticaria and Associated Determinants in Primary Care
Clinical &Experimental Allergy, Volume 56, Issue 3, Page 271-274, March 2026.
R. Soegiharto +6 more
wiley +1 more source
International Journal of Dermatology, Volume 65, Issue 3, Page 578-580, March 2026.
Ioannis‐Alexios Koumprentziotis +3 more
wiley +1 more source
Efficacy of Omalizumab therapy in a case of severe atopic dermatitis [PDF]
, 2011 Jonathan Barrios +2 more
core +1 more source
Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: A comparison of 3-year follow-up results from two prospective multicentre studies [PDF]
, 2017 Bansal, Sandeep +10 more
core +2 more sources